https://www.nasdaq.com/press-release/anixa-biosciences-to-participate-in-upcoming-january-investor-conferences%3a-lifesci
https://www.nasdaq.com/press-release/anixa-biosciences-and-molgenie-announce-that-their-covid-19-compounds-are-expected-to
https://www.nasdaq.com/press-release/anixa-biosciences-announces-patient-dosing-of-its-investigational-vaccine-candidate
https://www.nasdaq.com/press-release/anixa-biosciences-announces-first-chinese-patent-on-its-car-t-cancer-therapy
https://www.nasdaq.com/press-release/anixa-biosciences-announces-notice-of-allowance-for-additional-patent-on-its-car-t
https://www.nasdaq.com/press-release/anixa-biosciences-ovarian-cancer-car-t-therapy-to-be-discussed-at-upcoming-emerging
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-the-h.c.-wainwright-23rd-annual-global-investment
https://www.nasdaq.com/press-release/anixa-biosciences-appoints-dr.-pamela-garzone-as-chief-development-officer-2021-09-07
https://www.nasdaq.com/press-release/anixa-biosciences-and-moffitt-cancer-center-announce-fda-clearance-to-initiate
https://www.nasdaq.com/press-release/anixa-biosciences-covid-19-compounds-expected-to-be-effective-against-the-delta
https://www.nasdaq.com/press-release/anixa-biosciences-congratulates-director-dr.-arnold-baskies-for-his-appointment-to
https://www.nasdaq.com/press-release/anixa-biosciences-announces-issuance-of-u.s.-patent-for-ovarian-cancer-vaccine
https://www.nasdaq.com/press-release/anixa-biosciences-announces-support-from-the-national-cancer-institute-for-ovarian
https://www.nasdaq.com/press-release/anixa-biosciences-and-moffitt-cancer-center-receive-additional-information-request
https://www.nasdaq.com/press-release/ontochem-assigns-anixa-covid-19-drug-discovery-project-to-molgenie-2021-05-07
https://www.nasdaq.com/press-release/anixa-biosciences-and-moffitt-cancer-center-report-us-fda-request-of-additional
https://www.nasdaq.com/press-release/anixa-biosciences-and-ontochem-enter-next-stage-of-development-for-covid-19
https://www.nasdaq.com/press-release/anixa-biosciences-increases-previously-announced-bought-deal-offering-of-common-stock
https://www.nasdaq.com/press-release/anixa-biosciences-announces-%2410-million-bought-deal-offering-of-common-stock-2021-03
https://www.nasdaq.com/press-release/anixa-biosciences-and-moffitt-cancer-center-file-ind-application-for-ovarian-cancer
https://www.nasdaq.com/press-release/anixa-biosciences-announces-issuance-and-publication-of-european-patent-for-ovarian
https://www.nasdaq.com/press-release/anixa-biosciences-to-participate-in-m-vest-llc-and-maxim-group-llc-inaugural-emerging
https://www.nasdaq.com/press-release/anixa-biosciences-announces-european-patent-issued-for-its-car-t-cancer-therapy-2021
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-the-h.c.-wainwright-global-life-sciences-conference
https://www.nasdaq.com/press-release/anixa-biosciences-begins-animal-testing-of-covid-19-therapeutic-candidates-2021-02-16
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-the-b.-riley-oncology-investor-conference-2021-01-13
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-the-h.c.-wainwright-bioconnect-2021-conference-2021
https://www.nasdaq.com/press-release/anixa-biosciences-and-cleveland-clinic-announce-fda-clearance-to-initiate-clinical
https://www.nasdaq.com/press-release/anixa-biosciences-covid-19-therapy-demonstrates-comparable-potency-to-remdesivir-in
https://www.nasdaq.com/press-release/anixa-biosciences-announces-licensing-agreement-with-cleveland-clinic-for-ovarian
https://www.nasdaq.com/press-release/anixa-biosciences-and-cleveland-clinic-file-ind-application-for-breast-cancer-vaccine
https://www.nasdaq.com/press-release/anixa-biosciences-to-host-conference-call-to-provide-update-on-programs-2020-10-27
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-the-2020-h.c.-wainwright-22nd-annual-global
https://www.nasdaq.com/press-release/anixa-and-ontochem-announce-identification-of-additional-covid-19-compounds-2020-08
https://www.nasdaq.com/press-release/anixa-biosciences-breast-cancer-vaccine-technology-nearing-fda-submission-2020-07-28
https://www.nasdaq.com/press-release/anixa-biosciences-announces-change-to-virtual-format-for-2020-annual-meeting-of
https://www.nasdaq.com/press-release/anixa-biosciences-car-t-cancer-therapy-receives-intention-to-grant-notice-from-the
https://www.nasdaq.com/press-release/anixa-and-ontochem-announce-completion-of-initial-screening-program-and
https://www.nasdaq.com/press-release/anixa-announces-strategic-program-realignment-focused-on-advancement-of-its
https://www.nasdaq.com/press-release/anixa-biosciences-and-ontochem-have-synthesized-four-potential-covid-19-drugs-for
https://www.nasdaq.com/press-release/anixa-biosciences-and-ontochem-announce-discovery-of-first-covid-19-therapeutic
https://www.nasdaq.com/press-release/anixa-biosciences-announces-publication-of-peer-reviewed-journal-article-in-biomarker
https://www.nasdaq.com/press-release/anixa-biosciences-and-ontochem-announce-collaboration-to-develop-novel-covid-19
https://www.nasdaq.com/press-release/anixa-biosciences-announces-presentation-at-ai-and-big-data-in-cancer-conference-2020
https://www.nasdaq.com/press-release/anixa-biosciences-and-moffitt-cancer-center-announce-completion-of-viral-vector
https://www.nasdaq.com/press-release/anixa-biosciences-announces-presentation-at-aacr-liquid-biopsies-conference-2020-01
https://www.nasdaq.com/press-release/anixa-biosciences-announces-commercial-launch-of-cchektm-prostate-cancer-confirmatory
https://www.nasdaq.com/press-release/anixa-biosciences-to-host-conference-call-to-discuss-plans-for-2020-2019-12-13
https://www.nasdaq.com/press-release/anixa-biosciences-provides-update-on-car-t-program-2019-12-13
https://www.nasdaq.com/press-release/anixa-biosciences-announces-presentation-at-the-2019-san-antonio-breast-cancer
https://www.nasdaq.com/press-release/anixa-biosciences-announces-genesis-research-to-join-cchektm-prostate-cancer-study
https://www.nasdaq.com/press-release/anixa-biosciences-announces-collaboration-with-urology-centers-of-alabama-on-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-announces-collaboration-with-idaho-urologic-institute-on-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-announces-patent-issued-for-its-breast-cancer-vaccine-2019-11-05
https://www.nasdaq.com/press-release/anixa-biosciences-names-novartis-executive-dr.-emanuele-ostuni-to-scientific-advisory
https://www.nasdaq.com/press-release/anixa-biosciences-announces-collaboration-with-urology-san-antonio-on-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-announces-abstract-accepted-for-presentation-at-the-34th-annual
https://www.nasdaq.com/press-release/anixa-biosciences-appoints-dr.-thomas-schlumpberger-as-executive-vice-president-of
https://www.nasdaq.com/press-release/anixa-biosciences-names-cancer-vaccine-pioneer-dr.-ian-h.-frazer-to-scientific
https://www.nasdaq.com/press-release/anixa-biosciences-announces-university-of-maryland-school-of-medicine-to-join-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-commences-collaboration-with-potomac-urology-center-on-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-congratulates-scientific-advisory-board-member-dr.-h.-michael
https://www.nasdaq.com/press-release/anixa-biosciences-to-present-at-two-upcoming-investor-conferences-2019-08-26
https://www.nasdaq.com/press-release/anixa-biosciences-announces-va-north-texas-health-care-system-to-join-cchektm
https://www.nasdaq.com/press-release/anixa-biosciences-announces-additional-patent-issued-on-cancer-detection-technology
https://www.nasdaq.com/press-release/anixa-biosciences-announces-a-strategic-alliance-and-licensing-agreement-with
https://www.nasdaq.com/press-release/anixa-biosciences-highlights-recent-publication-in-the-journal-of-experimental
https://www.nasdaq.com/press-release/anixa-biosciences-present-cyto-2019-34th-congress-international-society-advancement
https://www.nasdaq.com/press-release/anixa-biosciences-announces-completion-cchektm-analytical-verification-clia
https://www.nasdaq.com/press-release/anixa-biosciences-present-b.-riley-fbr-institutional-investor-conference-2019-05-02
https://www.nasdaq.com/press-release/us-patent-trademark-office-issues-patent-anixa-biosciences-car-t-cancer-treatment
https://www.nasdaq.com/press-release/anixa-biosciences-extends-and-expands-its-collaboration-new-jersey-urology-2019-04-11
